Skip to main content
SpringerLink
Log in

Rocephin labelling updated

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Roche.Important prescribing information: update to the Rocephin (Rm) (ceftriaxone sodium) for Injection prescribing information thats provides new information in the contraindications, warnings, precautions, adverse reactions, dosage and administration sections. Prescribing Information: [2 pages], Jun 2007. Available from: URL: http://rocheusa.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rocephin labelling updated. React. Wkly. 1160, 2 (2007). https://doi.org/10.2165/00128415-200711600-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711600-00004

Keywords

Search

Navigation